Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

21 October 2002

Atrial fibrillation in the new millennium--the role of pacemaker and defibrillator therapy.

Andrew R.J. Mitchell

Med Sci Monit 2002; 8(10): RA233-239 :: ID: 4857

Abstract

Atrial fibrillation is the most common clinical arrhythmia and with an aging population it is becoming an increasing cause of morbidity and hospitalisation. Antiarrhythmic drug therapy unfortunately remains only moderately effective at preventing recurrences of arrhythmia. Attention has now therefore focussed on the development of non-drug techniques to prevent or treat atrial fibrillation in highly symptomatic patients. There are a number of theoretical ways that pacing the atrium may prevent arrhythmias and pacemakers are under investigation for the prevention and termination of atrial arrhythmias with additional tailored, programmable algorithms. The increased memory capacity and diagnostic capabilities of these devices allows the true efficacy of pacemaker interventions to be determined. Early results from studies suggest that the implantation of such pacemakers can reduce atrial fibrillation burden and thereby obviate the need for more invasive procedures such as atrioventricular nodal ablation. The improved diagnostics also provides enhanced information about the onset of atrial arrhythmias and suggests that atrial fibrillation may have periods of high organisation and a window for pace termination. The atrial defibrillator is a useful, but expensive, therapeutic option in patients with recurrent symptomatic persistent atrial fibrillation and the current generation of devices allow patients to activate the device at home using a hand-held activator. This reduces the need for hospitalisation and empowers the patient to 'take charge' of their condition.

Keywords: Atrial Fibrillation - mortality, Atrial Fibrillation - physiopathology

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750